MicroRNA 3664 (miR-3664)

MicroRNA 3664 (miR-3664, also known as hsa-miR-3664 or MIR3664) is a small, non-coding RNA molecule belonging to the microRNA family. MicroRNAs are short (about 22 nucleotides) regulatory RNAs that modulate gene expression by binding to target messenger RNAs (mRNAs), leading to their degradation or inhibition of translation[3][1]. miRNAs play key roles in cellular processes such as development, differentiation, proliferation, and apoptosis, and are especially important as post-transcriptional regulators of gene expression in both health and disease[3][4][5]. There is no evidence that MicroRNA 3664 is a therapeutic target in the sense of a receptor, enzyme, transporter, or similar druggable protein. Additionally, publicly available molecular biology and pharmacology data do not indicate any small-molecule or biological drugs that target miR-3664, nor is it a commonly used clinical biomarker. MiRNAs, in general, have been implicated in many diseases, including cancer, due to their regulatory role in gene networks[4][5], but for miR-3664 specifically, the scientific literature is sparse, and no unique disease associations are established at this time. This entry is considered **incorrect as a therapeutic target** because microRNAs are not direct druggable targets like proteins, though they may be involved in disease pathways or serve as indirect therapeutic modulators[2][3]. The designation "MIR3664" may refer to the genetic locus or precursor transcript rather than an actionable therapeutic molecule. If deeper information or drug-oriented structure is required, consult molecule-specific databases or recent reviews, as knowledge about less-studied miRNAs is rapidly evolving.

Other names

hsa-miR-3664mir-3664hsa-mir-3664MIR3664